Rhenman & Partners Asset Management’s Bio-Techne TECH Stock Holding History

Rhenman & Partners Asset Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,000	Closed	-$834K	–	103
2025 Q3	$834K	Hold	15,000	–	–	0.09%	91
2025 Q2	$772K	Buy	+15,000	New	+$754K	0.1%	89
2025 Q1	–	Sell	-3,000	Closed	-$216K	–	101
2024 Q4	$216K	Sell	3,000 -17,000	-85%	-$1.25M	0.02%	92
2024 Q3	$1.6M	Hold	20,000	–	–	0.13%	89
2024 Q2	$1.43M	Buy	20,000 +4,000	+25%	+$294K	0.14%	82
2024 Q1	$1.13M	Hold	16,000	–	–	0.11%	82
2023 Q4	$1.23M	Sell	16,000 -26,680	-63%	-$1.76M	0.12%	81
2023 Q3	$2.91M	Sell	42,680 -4,820	-10%	-$381K	0.31%	65
2023 Q2	$3.88M	Sell	47,500 -7,500	-14%	-$603K	0.41%	61
2023 Q1	$3.98M	Sell	55,000 -35,000	-39%	-$2.7M	0.44%	62
2022 Q4	$7.46M	Buy	+90,000	New	+$7.15M	0.78%	49

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Rhenman & Partners Asset Management's TECH Position: Q4 2025 in Review

Rhenman & Partners Asset Management sold out of Bio-Techne (TECH) in Q4 2025, closing a stake of 15,000 shares — an estimated $834K sold.

Rhenman & Partners Asset Management first reported a position in TECH in Q4 2022 and held it in 11 quarters. The position peaked at $7.46M in Q4 2022. 585 funds tracked by Wall St. Rank hold TECH as of Q4 2025.

Rhenman & Partners Asset Management reported no remaining Bio-Techne position as of Q4 2025 after selling out during the quarter.
Rhenman & Partners Asset Management sold 15,000 Bio-Techne shares in Q4 2025, an estimated $834K.
Rhenman & Partners Asset Management first reported a position in Bio-Techne in Q4 2022 and held it in 11 quarters.
Rhenman & Partners Asset Management's Bio-Techne position peaked at $7.46M in Q4 2022.
585 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2025.

Based on Rhenman & Partners Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.